Travere Therapeutics, Inc (NASDAQ:TVTX) Signals Bullish Rebound As Approval Date Delayed
![]() |
Commercial traction for FILSPARI and active regulatory news create a catalyst-rich near term; technical signals favor a controlled rebound while valuation metrics remain stretched. |








